Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
Abroad (travel likely)RecruitingPHASE2
Conditions
Diffuse Large B-Cell Lymphoma (DLBCL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China